Considering that VEGF damages the BBB in the acute stage of cerebral ischemia and protects the brain tissue in the recovery stage of cerebral ischemia, the time, dose and route of administration of VEGF after cerebral ischemia should be considered comprehensively to ensure that VEGF plays a protective role and to avoid adverse effects. The gene discussed is VEGFA; the disease is brain ischemia.